Resistance to immunotherapy urothelial bladder cancer patients traced to specific sets of immune cells

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Growing up in inner-city Detroit, Otis Brawley had a thriving community made up of his parents, Jesuit priests, friends, and neighbors encouraging him that he could do anything he put his mind to. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login